Frequency of low-grade adverse events and quality of life during chemotherapy determine patients' judgement about treatment in advanced-stage thoracic cancer

Research output: Contribution to journalArticleAcademicpeer-review

11 Citations (Scopus)
16 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)3563-3572
Number of pages10
JournalSupportive Care in Cancer
Volume27
Issue number9
DOIs
Publication statusPublished - 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research programs

  • EMC OR-01

Cite this